Reading room

Terapia August 2018 NR 8 ( 367 )

Hypertension

Editor of the issue: prof. dr hab. n. med. Andrzej Januszewicz, dr hab. n. med., prof. nadzw. IK Aleksander Prejbisz

Contents:

New ESC/ESH 2018 guidelines: evolution or revolution in antihypertensive therapy?

    Authors:
  • prof. dr hab. n. med. Aleksander Prejbisz
  • prof. dr hab. n. med. Andrzej Januszewicz
Keywords: hypertension, fixed-dose combination drugs, angiotensin converting enzyme inhibitors, calcium channel blockers, thiazide-type diuretics

Left ventricle hypertrophy: new insight on its impact in hypertension according to the ESC/ESH 2018 guidelines

    Authors:
  • prof. dr hab. n. med. Piotr Dobrowolski
  • dr hab. n. med., prof. nadzw. IK Anna Klisiewicz
  • prof. dr hab. n. med. Aleksander Prejbisz
  • prof. dr hab. n. med. Andrzej Januszewicz
  • prof. dr hab. n. med. Piotr Hoffman
Keywords: left ventricular hypertrophy, hypertension, echocardiography

ACE-inhibitor in combination with calcium channel blocker: foundation of hypertension treatment according to the new ESH/ESC 2018 guidelines?

    Authors:
  • prof. dr hab. n. med. Andrzej Januszewicz
  • prof. dr hab. n. med. Piotr Dobrowolski
  • prof. dr hab. n. med. Aleksander Prejbisz
Keywords: hypertension, ACE-inhibitor, calcium channel blocker, combination therapy

Beta-adrenolytics in the treatment of hypertension: new ESC/ESH 2018 guidelines

    Authors:
  • prof. dr hab. n. med. Aleksander Prejbisz
  • prof. dr hab. n. med. Piotr Dobrowolski
  • prof. dr hab. n. med. Andrzej Januszewicz
Keywords: hypertension, guidelines, β-adrenolytics, nebivolol

Diagnostics and treatment of patients with coexisting arterial hypertension and heart failure with preserved ejection fraction

    Authors:
  • prof. dr hab. n. med. Piotr Dobrowolski
  • dr hab. n. med., prof. nadzw. IK Anna Klisiewicz
  • prof. dr hab. n. med. Aleksander Prejbisz
  • prof. dr hab. n. med. Piotr Hoffman
Keywords: heart failure with preserved ejection fraction, arterial hypertension

New therapeutic strategy of hypertension: the place of spironalctone. ESC/ESH 2018 guidelines

    Authors:
  • prof. dr hab. n. med. Andrzej Januszewicz
  • prof. dr hab. n. med. Aleksander Prejbisz
Keywords: mineralocorticosteroid receptor antagonists, spironolactone, hypertension, resistant

Renal denervation in 2018: decline or new prospects for interventional treatment of hypertension?

    Authors:
  • dr n. med. Ewa Warchoł-Celińska
  • dr hab. n. med. Jacek Kądziela
  • prof. dr hab. n. med. Andrzej Januszewicz
  • prof. dr hab. n. med. Adam Witkowski
Keywords: renal denervation, hypertension, interventional treatment, cardiovascular risk

Treatment of hypertension in emodialysis patients with chronic kidney disease

    Authors:
  • prof. dr hab. n. med. Marcin Adamczak
  • lek. Patrycja Pokora
  • lek. Sylwia Dudzicz
  • prof. dr hab. n. med. Andrzej Więcek
Keywords: hypertension, hemodialysis, chronic kidney disease

New life for well known antihypertensive drugs: outdated or irreplaceable?

    Authors:
  • prof. dr hab. n. med. Aleksander Prejbisz
  • prof. dr hab. n. med. Piotr Dobrowolski
  • prof. dr hab. n. med. Andrzej Januszewicz
Keywords: angiotensin converting enzyme inhibitors, calcium channel blockers, lercanidipine, enalapril, efficacy, guidelines, tolerability

Between Scylla and Charybdis: treatment of hypertension in elderly and very elderly patients - more or less intensive?

    Authors:
  • prof. dr hab. n. med. Aleksander Prejbisz
  • prof. dr hab. n. med. Piotr Dobrowolski
  • prof. dr hab. n. med. Andrzej Januszewicz
Keywords: hypertension, guidelines, treatment goals, calcium channel blockers, thiazide-type diuretics, elderly, very elderly